In partnership with Acute Leukemia Advocates Network we support patients and caregivers as they navigate life with #AML. Watch the latest episode of our “Blood Cancer, Explained” series to hear more: https://bit.ly/3MvGdpN [Video description: Samantha Nier, Network Director of Acute Leukemia Advocates Network, discusses reiterating the availability of resources to patients and caregivers throughout the AML care journey.]
About us
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
External link for AbbVie
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- North Chicago, Illinois
- Type
- Public Company
- Specialties
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
Locations
Employees at AbbVie
Updates
-
#Migraine is a debilitating neurological disease. Through our research and connection with the patient community, we have a deep understanding of the burden and its daily impact. Join us in helping elevate these patients' voices and bringing awareness to the severity of this disease. Hear more from our own employees living with migraine: https://bit.ly/3z4uz23 [Video description: AbbVie employees living with migraine share how the company supports them.]
-
This World #CLL Awareness Day, we’re highlighting opportunities to help address the unmet needs of people touched by CLL globally. Stay tuned for our global CLL impact report to be shared later this year, which will provide a closer look at how CLL affects global communities. #WCLLD24 [Image description: On-screen text reads, “Many patients report that the emotional journey of CLL begins at diagnosis. It can feel more insurmountable than the physical effects of the disease at times. That’s one of the reasons why AbbVie is exploring the emotional impact of CLL in our upcoming global report. Stay tuned for our full global report coming later this year.”]
-
Today, we’re celebrating #WomensEqualityDay by recognizing the powerful contributions of the women in our organization. Their impact is felt throughout our workplace and in the communities where we work and live. #BelongAtAbbVie [Video description: An animated photo collage of women at AbbVie. On-screen text reads, "Happy Women's Equality Day to all the women helping us make a remarkable impact."]
-
Following the European Commission’s conditional marketing authorization in relapsed/refractory follicular #lymphoma, in partnership with Genmab, Jacqueline Nielsen, Ph.D., Therapeutic Head, Hematology at AbbVie, shares the importance of this milestone for #BloodCancer patients. Explore our research in #oncology: https://bit.ly/4cAoB71 [Image description: Jacqueline Nielsen, Ph.D., Therapeutic Head, Hematology, AbbVie, says, “This milestone advances our commitment to elevating care for people living with cancer.”]
-
-
Proud to announce we've received a top score on this year's Inclusion Index from Seramount for fostering a workplace culture that encourages diversity, inclusion and employee growth. Read more: https://bit.ly/46QrHCt #BelongAtAbbVie #InclusionIndex2024
-
-
JUST IN: The European Commission has granted conditional marketing authorization in relapsed/refractory follicular #lymphoma, a form of #BloodCancer, after two or more lines of prior therapy, developed in collaboration with Genmab. Read more: https://bit.ly/3AyFvWb [Video description: On-screen text reads, “Oncology News.”]
-
Join us in congratulating Tim Richmond, our executive vice president and chief human resources officer, on receiving the HR Division - Academy of Management's 2024 "Distinguished HR Executive Award" for his #leadership in advancing the #HumanResources management field. This award highlights Tim’s contributions to the HR practice, including his ongoing support of HR research and education. As a member of our executive leadership team, Tim and the HR team he leads enable our growth and help make us one of the world’s best workplaces.
-
-
Earlier this year, our employees across the globe participated in AbbVie In Motion, our annual team-based movement and activity challenge. See how we make employee health and well-being one of our top priorities: https://bit.ly/3yzcby5 #AbbVieLife [Video description: Images and statistics recapping the impact of AbbVie in Motion around the world, including 16K+ participants; 1,400+ teams from 69 countries; more than 25M total physical activity minutes logged.]
-
Thank you to our 13,000+ employees who served their local #communities during Week of Possibilities, the AbbVie Foundation’s annual #volunteer event. Together they spent nearly 50,000 hours contributing to numerous community projects around the globe, including renovating and improving schools, serving meals, building homes, cleaning up waterways and more. See the full impact of their volunteering: https://bit.ly/4dyXFoQ #AbbVieGivesBack [Video description: Interviews with AbbVie employees talking about volunteering during Week of Possibilities and footage of volunteer activities.]
Affiliated pages
Similar pages
Browse jobs
Stock
ABBV
NYSE
20 minutes delay
$197.92
0.23 (0.116%)
- Open
- 198.69
- Low
- 197.63
- High
- 199.88
Data from Refinitiv
See more info on